Table 1. Clinical Characteristics During... | American Society of Hematology

Table 1.

Clinical Characteristics During the Hospital Course of the Placebo-Treated Patients and Episodes Occurring in Eligible Patients Who Were Not Enrolled on the Study

	Placebotreated Patients (n = 21)	Not Enrolled on Study (n = 20)	P Value
Length of hospitalization (h)
Mean	80	96	.62^*
Range	34-245	19-688
SD	50	137
Duration of fever (h)
Mean	53	84	.37^*
Range	13-128	5-672
SD	34	154
Duration of oxygen therapy (h)
Mean	60	62	.88^*
Range	9-162	19-139
SD	43	38
Mean duration of opioid therapy (h)
Mean	77	79	.89^*
Range	37-123	14-144
SD	31	48
ACS episodes that required blood transfusions	10 (47%)	11 (55%)	.88^-151
Number of patients requiring intensive care	2 (9.5%)	2 (10%)	.96^-151

	Placebotreated Patients (n = 21)	Not Enrolled on Study (n = 20)	P Value
Length of hospitalization (h)
Mean	80	96	.62^*
Range	34-245	19-688
SD	50	137
Duration of fever (h)
Mean	53	84	.37^*
Range	13-128	5-672
SD	34	154
Duration of oxygen therapy (h)
Mean	60	62	.88^*
Range	9-162	19-139
SD	43	38
Mean duration of opioid therapy (h)
Mean	77	79	.89^*
Range	37-123	14-144
SD	31	48
ACS episodes that required blood transfusions	10 (47%)	11 (55%)	.88^-151
Number of patients requiring intensive care	2 (9.5%)	2 (10%)	.96^-151

*Student t-test for two independent groups.

F0-151

Chi-square contingency table analysis or Fisher exact test.

View Large

This Feature Is Available To Subscribers Only